Day One Biopharmaceuticals (DAWN) Earnings Date & Reports
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
DAWN is expected to report earnings to fall 33.67% to -41 cents per share on May 07
Q1'25
Est.
$-0.42
Q4'24
Missed
by $0.17
Q3'24
Beat
by $0.70
Q2'24
Beat
by $0.70
Q1'24
Missed
by $0.07
The last earnings report on February 25 showed earnings per share of -62 cents, missing the estimate of -46 cents. With 580.76K shares outstanding, the current market capitalization sits at 754.07M.